Head of Market Access Operations

What Impact Will I Make?As Head of Market Access Operations & HUB Services, you will lead the strategy, execution, and evolution of Glaukos' patient access ecosystem, ensuring patients can access our therapies quickly, efficiently, and with minimal barriers. You will build and scale innovative patient support capabilities that improve speed-to-therapy, enhance provider and patient experiences, and support the successful commercialization of both current and future therapies.Serving as the enterprise leader for HUB services, affordability programs, specialty pharmacy operations, and Patient Access Liaison capabilities, you will partner across Market Access, Commercial, Marketing, Technology, Legal, Compliance, Finance, and Medical Affairs to build scalable, patient-centered programs that support our growing portfolio and advance Glaukos' mission to transform lives through vision.What Will I Do?Lead the strategy, design, and continuous optimization of Glaukos' HUB services, patient support programs, affordability offerings, specialty pharmacy partnerships, and Patient Access Liaison capabilities.Develop innovative solutions that improve speed-to-therapy, patient adherence, provider satisfaction, and the overall customer experience while supporting both current and future product launches.Provide executive oversight of HUB vendors, specialty pharmacy providers, affordability partners, and patient support operations, ensuring strong performance, compliance, accountability, and operational excellence.Leverage data, analytics, and technology-enabled solutions to drive continuous improvement, inform strategic decision-making, and enhance business performance across the patient access ecosystem.Build, develop, and inspire a high-performing team while fostering a culture of innovation, collaboration, accountability, and unwavering commitment to helping patients access transformative therapies.How Will I Get There?Bachelor's degree in Business, Healthcare Administration, Life Sciences, or a related field required; MBA or other advanced degree preferred.12+ years of experience within the biotechnology, pharmaceutical, medical device, specialty therapeutics, or broader healthcare industry, including 8+ years of progressive leadership experience in patient services, market access operations, HUB services, specialty pharmacy, reimbursement support, or patient access programs.Proven success designing, building, scaling, and optimizing patient support capabilities that support commercial products, growth-stage brands, lifecycle expansion opportunities, and new product launches.Demonstrated experience leading complex patient support programs within specialty pharmacy, buy-and-bill, biologics, rare disease, or other access-intensive therapeutic environments requiring sophisticated reimbursement and access strategies.Deep understanding of HUB operations, patient support programs, affordability offerings, specialty pharmacy networks, reimbursement ecosystems, and the evolving patient access landscape.Strong knowledge of healthcare compliance requirements, including HIPAA, OIG guidance, privacy regulations, patient support governance standards, FDA regulations, and operational controls that ensure compliant program execution.Experience leading complex vendor relationships, governance models, performance management frameworks, service-level agreements, contract optimization initiatives, and external partner oversight.Advanced analytical and business intelligence capabilities with the ability to leverage operational data, performance metrics, and customer insights to drive strategic decisions, continuous improvement, and innovation.Exceptional communication, stakeholder management, and influencing skills, with a demonstrated ability to lead cross-functional initiatives and build alignment across matrixed organizations and executive leadership teams.Strategic, customer-focused leader with a passion for innovation, operational excellence, talent development, and improving experiences for patients, caregivers, and healthcare providers while balancing long-term vision with day-to-day execution.

#GKOSUS

Generous. Innovative. Leadership-driven. Family-oriented. Socially responsible. Founded in 1998, Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.Our mission at Glaukos is to truly transform vision by pioneering novel, dropless therapies that can meaningfully advance the standard of care and improve the lives of patients suffering from chronic, sight-threatening eye diseases. Innovation is at the core of everything we do, and we are resolute in our commitment to challenge conventional thinking with new treatment alternatives that are supported by real science, robust clinical evidence, and an unrelenting focus on patients. Our constant pursuit of game-changing technologies that disrupt legacy treatment paradigms is encapsulated in the Glaukos mantra “We’ll Go First,” which articulates our willingness to take chances, our determination to forge new ground, and our commitment to continuous improvement in all that we do. Our company completed an initial public offering in June of 2015, and our shares are traded on the New York Stock Exchange under the ticker symbol “GKOS”. Our global headquarters is in Aliso Viejo, California with additional locations in San Clemente, California, and Burlington, Massachusetts.Glaukos Corporation is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex including sexual orientation and gender identity, national origin, disability, protected Veteran Status, or any other characteristic protected by applicable federal, state, or local law. All offers of employment are contingent upon the successful completion of a background check, including successfully passing a drug screen, based on the position and local regulations.Full timePosting Date: 2026-08-21